| scholarly article | Q13442814 |
| P2093 | author name string | A Jackson | |
| J Moxham | |||
| M I Polkey | |||
| N S Hopkinson | |||
| E F M Wouters | |||
| A M W J Schols | |||
| H R Gosker | |||
| W D-C Man | |||
| S A Natanek | |||
| M A Spruit | |||
| J M Seymour | |||
| P2860 | cites work | Skeletal muscle dysfunction in chronic obstructive pulmonary disease. A statement of the American Thoracic Society and European Respiratory Society | Q77293166 |
| Muscle fatigue resistance during stimulated contractions is reduced in young male smokers | Q80432169 | ||
| Are patients with COPD more active after pulmonary rehabilitation? | Q81058366 | ||
| Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease | Q22299313 | ||
| Standardisation of the measurement of lung volumes | Q28269989 | ||
| Standardisation of the single-breath determination of carbon monoxide uptake in the lung | Q28275504 | ||
| Standardisation of spirometry | Q29547365 | ||
| ATS Statement | Q34136219 | ||
| The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease | Q34546085 | ||
| Quadriceps muscle strength in scoliosis | Q34775630 | ||
| Non-volitional assessment of skeletal muscle strength in patients with chronic obstructive pulmonary disease. | Q35536063 | ||
| A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease. | Q35699591 | ||
| Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease | Q36203206 | ||
| Randomised controlled trial of weightlifting exercise in patients with chronic airflow limitation | Q36255832 | ||
| Attacking the disease spiral in chronic obstructive pulmonary disease. | Q36475246 | ||
| Skeletal muscle properties and fatigue resistance in relation to smoking history. | Q36785046 | ||
| Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care | Q42120501 | ||
| Metabolic characteristics of the deltoid muscle in patients with chronic obstructive pulmonary disease | Q43697577 | ||
| Bedside methods versus dual energy X-ray absorptiometry for body composition measurement in COPD. | Q43985168 | ||
| Acute effect of oral steroids on muscle function in chronic obstructive pulmonary disease | Q45006896 | ||
| Peripheral muscle alterations in non-COPD smokers | Q46813640 | ||
| Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study | Q47665346 | ||
| Angiotensin converting enzyme genotype and strength in chronic obstructive pulmonary disease | Q47987827 | ||
| Quadriceps fatigue after cycle exercise in patients with COPD compared with healthy control subjects. | Q48631544 | ||
| Extra-pulmonary features in COPD patients entering rehabilitation after stratification for MRC dyspnea grade. | Q50889560 | ||
| Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study. | Q51896643 | ||
| Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. | Q55067747 | ||
| The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. | Q55485607 | ||
| A novel technique for nonvolitional assessment of quadriceps muscle endurance in humans | Q56508004 | ||
| Ultrasound measurement of rectus femoris cross-sectional area and the relationship with quadriceps strength in COPD | Q60441819 | ||
| Human skeletal muscle function: description of tests and normal values | Q67555754 | ||
| A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire | Q68139804 | ||
| Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation | Q70687502 | ||
| Quadriceps strength and fatigue assessed by magnetic stimulation of the femoral nerve in man | Q71051010 | ||
| Peripheral muscle weakness contributes to exercise limitation in COPD | Q71078804 | ||
| Corticosteroids contribute to muscle weakness in chronic airflow obstruction | Q72047162 | ||
| Muscle weakness is related to utilization of health care resources in COPD patients | Q73094085 | ||
| Skeletal muscle weakness is associated with wasting of extremity fat-free mass but not with airflow obstruction in patients with chronic obstructive pulmonary disease | Q73509656 | ||
| P433 | issue | 1 | |
| P921 | main subject | chronic obstructive pulmonary disease | Q199804 |
| P304 | page(s) | 81-88 | |
| P577 | publication date | 2009-11-06 | |
| P1433 | published in | European Respiratory Journal | Q12257435 |
| P1476 | title | The prevalence of quadriceps weakness in COPD and the relationship with disease severity | |
| P478 | volume | 36 |
| Q38969953 | "What are my chances of developing COPD if one of my parents has the disease?" A systematic review and meta-analysis of prevalence of co-occurrence of COPD diagnosis in parents and offspring |
| Q97419442 | 2011 GOLD Stages of COPD: Transitions, Predictor Factors and Comparison with 2017 GOLD Stages |
| Q47212268 | 3D Ultrasound Imaging: Fast and Cost-effective Morphometry of Musculoskeletal Tissue. |
| Q34299825 | A randomized controlled trial of angiotensin-converting enzyme inhibition for skeletal muscle dysfunction in COPD. |
| Q37704113 | ACE and response to pulmonary rehabilitation in COPD: two observational studies. |
| Q38221125 | Activity restriction in mild COPD: a challenging clinical problem |
| Q92618537 | Additional Effects of Nutritional Antioxidant Supplementation on Peripheral Muscle during Pulmonary Rehabilitation in COPD Patients: A Randomized Controlled Trial |
| Q33901722 | An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease |
| Q36256581 | Analysis of three different equations for predicting quadriceps femoris muscle strength in patients with COPD. |
| Q57097245 | Animal models of chronic obstructive pulmonary disease |
| Q47581339 | Ankle dorsiflexor muscle size, composition and force with ageing and chronic obstructive pulmonary disease |
| Q37346053 | Ascorbate infusion increases skeletal muscle fatigue resistance in patients with chronic obstructive pulmonary disease. |
| Q38917425 | Aspects of skeletal muscles in chronic respiratory disease |
| Q43185219 | Assessing quadriceps muscle strength as a tool to determine the approach to and prognosis in COPD patients |
| Q90713990 | Association among chronic kidney disease, airflow limitation, and mortality in a community-based population: The Yamagata (Takahata) study |
| Q30412418 | Association between quadriceps strength and self-reported physical activity in people with knee osteoarthritis |
| Q82243541 | Attacking the disease spiral in chronic obstructive pulmonary disease: an update |
| Q47704663 | Balance and Falls in Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Prospective Study |
| Q36185926 | Bedside assessment of quadriceps muscle by ultrasound after admission for acute exacerbations of chronic respiratory disease. |
| Q86968722 | Beneficial effect of NMES in COPD wanes after programme completion |
| Q45819992 | Bone attenuation on routine chest CT correlates with bone mineral density on DXA in patients with COPD. |
| Q46302607 | Breathlessness and skeletal muscle weakness in patients undergoing lung health screening in primary care. |
| Q61805063 | Bufei Jianpi Granules Reduce Quadriceps Muscular Cell Apoptosis by Improving Mitochondrial Function in Rats with Chronic Obstructive Pulmonary Disease |
| Q35228335 | Bufei Jianpi granules improve skeletal muscle and mitochondrial dysfunction in rats with chronic obstructive pulmonary disease |
| Q58778491 | COPD is accompanied by co-ordinated transcriptional perturbation in the quadriceps affecting the mitochondria and extracellular matrix |
| Q38264345 | COPD: early diagnosis and treatment to slow disease progression. |
| Q34436393 | COPD: maximization of bronchodilation |
| Q38169870 | Chronic obstructive pulmonary disease and comorbidities |
| Q39490441 | Chronic obstructive pulmonary disease and functioning: implications for rehabilitation based on the ICF framework |
| Q37988881 | Chronic obstructive pulmonary disease: consequences beyond the lung. |
| Q37528272 | Clinical management of chronic obstructive pulmonary disease patients with muscle dysfunction |
| Q28392443 | Cluster Analysis in Patients with GOLD 1 Chronic Obstructive Pulmonary Disease |
| Q35026147 | Comorbidity and health-related quality of life in patients with severe chronic obstructive pulmonary disease attending Swedish secondary care units |
| Q37127155 | Correlation between Limb Muscle Endurance, Strength, and Functional Capacity in People with Chronic Obstructive Pulmonary Disease. |
| Q47734308 | Deterioration of Limb Muscle Function During Acute Exacerbation of Chronic Obstructive Pulmonary Disease |
| Q64911006 | Determining the minimally important difference in quadriceps strength in individuals with COPD using a fixed dynamometer. |
| Q34279922 | Differences in walking pattern during 6-min walk test between patients with COPD and healthy subjects |
| Q35205327 | Do epigenetic events take place in the vastus lateralis of patients with mild chronic obstructive pulmonary disease? |
| Q35619124 | Downregulation of the serum response factor/miR-1 axis in the quadriceps of patients with COPD. |
| Q37677934 | Eccentric Ergometer Training Promotes Locomotor Muscle Strength but Not Mitochondrial Adaptation in Patients with Severe Chronic Obstructive Pulmonary Disease |
| Q42673163 | Echo intensity of the rectus femoris in stable COPD patients |
| Q60922097 | Effect and feasibility of non-linear periodized resistance training in people with COPD: study protocol for a randomized controlled trial |
| Q47123851 | Effect of an intensive 3-week preoperative home rehabilitation programme in patients with chronic obstructive pulmonary disease eligible for lung cancer surgery: a multicentre randomised controlled trial |
| Q64245613 | Effects of Different Comorbidities on Health-Related Quality of Life among Respiratory Patients in Vietnam |
| Q92934337 | Effects of Pulmonary Rehabilitation on Gait Characteristics in Patients with COPD |
| Q55349415 | Effects of aging and comorbidities on nutritional status and muscle dysfunction in patients with COPD. |
| Q47655224 | Effects of simple long-term respiratory care strategies in older men with COPD. |
| Q34582226 | Efficacy of a physical exercise training programme COPD in primary care: study protocol of a randomized controlled trial |
| Q36850787 | Epigenetic regulation of muscle phenotype and adaptation: a potential role in COPD muscle dysfunction |
| Q38209274 | Epigenetics and muscle dysfunction in chronic obstructive pulmonary disease |
| Q46178928 | Evaluating the role of inflammation in chronic airways disease: the ERICA study |
| Q47677157 | Evolution of Diaphragm Thickness during Mechanical Ventilation. Impact of Inspiratory Effort |
| Q37940008 | Extrapulmonary comorbidities in chronic obstructive pulmonary disease: state of the art. |
| Q35099434 | Factors associated with impairment of quadriceps muscle function in Chinese patients with chronic obstructive pulmonary disease |
| Q47130400 | Formoterol attenuates increased oxidative stress and myosin protein loss in respiratory and limb muscles of cancer cachectic rats. |
| Q43239141 | Functionally Relevant Cut Point for Isometric Quadriceps Muscle Strength in Chronic Respiratory Disease. |
| Q35807283 | Heterogeneity of Systemic Oxidative Stress Profiles in COPD: A Potential Role of Gender |
| Q46210278 | Heterogeneity of quadriceps muscle phenotype in chronic obstructive pulmonary disease (Copd); implications for stratified medicine? |
| Q37346083 | Increased skeletal muscle-specific microRNA in the blood of patients with COPD. |
| Q42603766 | Inhibition of AMPK expression in skeletal muscle by systemic inflammation in COPD rats |
| Q40867599 | Insulin resistance is associated with skeletal muscle weakness in COPD. |
| Q61445342 | Inter-day test–retest reliability and feasibility of isokinetic, isometric, and isotonic measurements to assess quadriceps endurance in people with chronic obstructive pulmonary disease: A multicenter study |
| Q36104189 | Involvement of the FoxO1/MuRF1/Atrogin-1 Signaling Pathway in the Oxidative Stress-Induced Atrophy of Cultured Chronic Obstructive Pulmonary Disease Myotubes |
| Q33649907 | Is periodontitis a comorbidity of COPD or can associations be explained by shared risk factors/behaviors? |
| Q97521773 | Is vaping better than smoking for cardiorespiratory and muscle function? |
| Q57777303 | Ischiocrural Strength May Be a Better Prognostic Marker Than Quadriceps Strength in COPD |
| Q38705507 | Leisure time sedentary behavior, physical activity and frequency of protein consumption on lower extremity strength and lean mass. |
| Q93013804 | Locomotor Muscles in COPD: The Rationale for Rehabilitative Exercise Training |
| Q41898535 | Long-term nose-only cigarette smoke exposure induces emphysema and mild skeletal muscle dysfunction in mice |
| Q52903989 | Low-load/high-repetition elastic band resistance training in patients with COPD: a randomized, controlled, multicenter trial. |
| Q38243468 | Lung hyperinflation in chronic obstructive pulmonary disease: mechanisms, clinical implications and treatment |
| Q27005858 | Managing comorbidities in COPD |
| Q34539228 | Metabolic load during strength training or NMES in individuals with COPD: results from the DICES trial |
| Q39085780 | Metabolism and Skeletal Muscle Homeostasis in Lung Disease. |
| Q39332602 | Mild chronic obstructive pulmonary disease: why spirometry is not sufficient! |
| Q30251635 | Molecular and biological pathways of skeletal muscle dysfunction in chronic obstructive pulmonary disease |
| Q38219063 | Moving towards patient-centered medicine for COPD management: multidimensional approaches versus phenotype-based medicine--a critical view |
| Q37728557 | MuRF-1 and atrogin-1 protein expression and quadriceps fiber size and muscle mass in stable patients with COPD. |
| Q38024726 | Muscle atrophy in aging and chronic diseases: is it sarcopenia or cachexia? |
| Q55397599 | Muscle atrophy in chronic obstructive pulmonary disease: molecular basis and potential therapeutic targets. |
| Q35262077 | Muscle dysfunction in patients with lung diseases: a growing epidemic |
| Q26865732 | Muscle function in COPD: a complex interplay |
| Q47707727 | Muscle regeneration potential and satellite cell activation profile during recovery following hindlimb immobilization in mice |
| Q35580654 | Muscular and functional effects of partitioning exercising muscle mass in patients with chronic obstructive pulmonary disease - a study protocol for a randomized controlled trial |
| Q42181451 | Musculoskeletal disorders in chronic obstructive pulmonary disease |
| Q40174334 | Neuromuscular electrical stimulation to improve exercise capacity in patients with severe COPD: a randomised double-blind, placebo-controlled trial |
| Q92861404 | New insights into early intervention of chronic obstructive pulmonary disease with mild airflow limitation |
| Q55212210 | Nutritional status and muscle dysfunction in chronic respiratory diseases: stable phase versus acute exacerbations. |
| Q26995338 | Nutritional support and functional capacity in chronic obstructive pulmonary disease: a systematic review and meta-analysis |
| Q58102822 | Oxygen Uptake, Ventilation, and Symptoms During Low-Frequency Versus High-Frequency NMES in COPD: A Pilot Study |
| Q47782918 | Palliative care and management of troublesome symptoms for people with chronic obstructive pulmonary disease |
| Q38091961 | Pathophysiology of muscle dysfunction in COPD. |
| Q35749536 | Peak oxygen uptake and breathing pattern in COPD patients--a four-year longitudinal study |
| Q35044390 | Physical activity level and its clinical correlates in chronic obstructive pulmonary disease: a cross-sectional study |
| Q37398866 | Physical frailty and pulmonary rehabilitation in COPD: a prospective cohort study. |
| Q54967201 | Physical inactivity is associated with decreased growth differentiation factor 11 in chronic obstructive pulmonary disease. |
| Q37501498 | Preserved function and reduced angiogenesis potential of the quadriceps in patients with mild COPD |
| Q36036917 | Prevalence of quadriceps muscle weakness in patients with COPD and its association with disease severity |
| Q38588362 | Preventive Role of Tetraspanin CD9 in Systemic Inflammation of Chronic Obstructive Pulmonary Disease |
| Q30354982 | Protein carbonylation and muscle function in COPD and other conditions. |
| Q40214070 | Protein timing during the day and its relevance for muscle strength and lean mass. |
| Q39292312 | Pulmonary Rehabilitation Improves Outcomes in Chronic Obstructive Pulmonary Disease Independent of Disease Burden |
| Q45776544 | Pulmonary rehabilitation and COPD: is nonlinear exercise better? |
| Q42173491 | Quadriceps muscle weakness and atrophy are associated with a differential epigenetic profile in advanced COPD. |
| Q92974941 | Quadriceps strength in patients with chronic obstructive pulmonary disease |
| Q37559620 | Rectus Femoris Cross-Sectional Area and Muscle Layer Thickness: Comparative Markers of Muscle Wasting and Weakness. |
| Q33708989 | Reduced HDAC2 in skeletal muscle of COPD patients |
| Q35934965 | Relation between systemic inflammatory markers, peripheral muscle mass, and strength in limb muscles in stable COPD patients. |
| Q51365018 | Relationship between body composition, peripheral muscle strength and functional exercise capacity in patients with severe chronic obstructive pulmonary disease. |
| Q38023517 | Renin-angiotensin system blockade: a novel therapeutic approach in chronic obstructive pulmonary disease |
| Q38273324 | Respiratory and Limb Muscle Dysfunction in COPD. |
| Q41450305 | Respiratory constraints during activities in daily life and the impact on health status in patients with early-stage COPD: a cross-sectional study |
| Q37979250 | Respiratory diseases and muscle dysfunction |
| Q89629336 | Risk assessment for hospital admission in patients with COPD; a multi-centre UK prospective observational study |
| Q37566391 | Role of Protein Carbonylation in Skeletal Muscle Mass Loss Associated with Chronic Conditions |
| Q48987375 | Role of extra-pulmonary factors – depression, muscle weakness, health-related quality of life – in COPD evolution. |
| Q38786398 | Sarcopenia and frailty in chronic respiratory disease. |
| Q64903347 | Sex differences in COPD-related quadriceps muscle dysfunction and fibre abnormalities. |
| Q47149227 | Sex differences in function and structure of the quadriceps muscle in chronic obstructive pulmonary disease patients. |
| Q50226668 | Short- and Long-Term Hindlimb Immobilization and Reloading: Profile of Epigenetic Events in Gastrocnemius. |
| Q34436903 | Skeletal muscle adiposity is associated with physical activity, exercise capacity and fibre shift in COPD |
| Q36162963 | Smoking and Early COPD as Independent Predictors of Body Composition, Exercise Capacity, and Health Status. |
| Q38315605 | Smoking-induced skeletal muscle dysfunction: from evidence to mechanisms |
| Q92404706 | Specific motor cortex hypoexcitability and hypoactivation in COPD patients with peripheral muscle weakness |
| Q37644954 | Structural alterations of skeletal muscle in copd. |
| Q38056532 | Systemic inflammatory biomarkers and co-morbidities of chronic obstructive pulmonary disease |
| Q92559634 | TCM nonpharmacological interventions for chronic obstructive pulmonary disease (COPD): Protocol for a systematic review and network meta-analysis |
| Q26795662 | Targeting oxidant-dependent mechanisms for the treatment of COPD and its comorbidities |
| Q38109909 | The COPD Biomarker Qualification Consortium (CBQC). |
| Q41307834 | The Relationship of Bone Mineral Density in Men with Chronic Obstructive Pulmonary Disease Classified According to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Combined Chronic Obstructive Pulmonary Disease (COPD) Assessment Sys |
| Q33553606 | The continuum of physiological impairment during treadmill walking in patients with mild-to-moderate COPD: patient characterization phase of a randomized clinical trial |
| Q48222148 | The five-repetition sit-to-stand test as a functional outcome measure in COPD. |
| Q36288944 | The one repetition maximum test and the sit-to-stand test in the assessment of a specific pulmonary rehabilitation program on peripheral muscle strength in COPD patients. |
| Q36240664 | The phenotype of concurrent chronic bronchitis and frequent exacerbations in patients with severe COPD attending Swedish secondary care units |
| Q39411799 | The relationship between coping styles and clinical outcomes in patients with COPD entering pulmonary rehabilitation |
| Q38878269 | The role of MicroRNAs in COPD muscle dysfunction and mass loss: implications on the clinic |
| Q47148974 | Tumor necrosis factor-like weak inducer of apoptosis regulates quadriceps muscle atrophy and fiber-type alteration in a rat model of chronic obstructive pulmonary disease |
| Q89536927 | Ultrasound Evaluation of the Quadriceps Muscle Contractile Index in Patients with Stable Chronic Obstructive Pulmonary Disease: Relationships with Clinical Symptoms, Disease Severity and Diaphragm Contractility |
| Q51449471 | Using laser capture microdissection to study fiber specific signaling in locomotor muscle in COPD: A pilot study. |
| Q40095922 | Validity and reliability of strain gauge measurement of volitional quadriceps force in patients with COPD. |
| Q42993162 | Vastus lateralis fiber shift is an independent predictor of mortality in chronic obstructive pulmonary disease |
| Q28397350 | Vitamin D deficiency and airflow limitation in the Baltimore Longitudinal Study of Ageing |
| Q47962116 | Vitamin D status is associated with bone mineral density and functional exercise capacity in patients with chronic obstructive pulmonary disease |
| Q38553569 | Why and How Limb Muscle Mass and Function Should Be Measured in Patients with Chronic Obstructive Pulmonary Disease. |
| Q47688387 | miR-422a suppresses SMAD4 protein expression and promotes resistance to muscle loss |
| Q43966274 | p38 mitogen-activated protein kinase is not activated in the quadriceps of patients with stable chronic obstructive pulmonary disease |
Search more.